J Am Med Inform Assoc. 2026 Aug 6:ocag135. doi: 10.1093/jamia/ocag135. Online ahead of print.
ABSTRACT
OBJECTIVE: This study aimed to identify trajectories of multimorbidity following acute myocardial infarction (AMI), using explainable temporal machine-learning methods, and assess their clinical, prognostic, and biological significance.
MATERIALS AND METHODS: Dynamic Time Warping k-means clustering was applied to post-AMI diagnostic sequences from 12 701 UK-Biobank participants. Latent Dirichlet Allocation characterised cluster themes. Multiclass classifiers (CatBoost, XGBoost, random forest, logistic regression) trained on pre-AMI diagnoses and demographics predicted trajectory membership, with SHAP interpretability. SMART scores and Cox models evaluated 5-year mortality; Phenotype-Wide Association (PheWAS) and Reactome pathway enrichment were used to identify associated biological mechanisms.
RESULTS: Three trajectories of multimorbidity were identified: acute cardiorenal-respiratory with metabolic disease (ACUTE-CARD; 63.4%), cardiometabolic disease with arrhythmic-ischemic burden (CARDIOMIX; 13.5%), and smoking-related multisystem multimorbidity (SMO-CARD; 23.1%). XGBoost achieved the highest discrimination (AUC-ROC 0.906; 95% CI, 0.895-0.916), with CatBoost showing comparable performance (AUC-ROC 0.900; 95% CI, 0.889-0.910). SMO-CARD had the highest 5-year mortality (43.9%). The established SMART cardiovascular risk score remained the dominant predictor of mortality while the identified trajectories provided complementary prognostic signals; these associations were weaker after full adjustment for potential confounders with each profile displaying distinct genetic and pathway signatures.
DISCUSSION: The SMART score outperformed in capturing mortality risk, whereas the trajectories complement it by revealing nuanced clustering of risk factors across organ systems and in identifying trajectory-specific intervention priorities.
CONCLUSION: Explainable temporal modeling of EHR data reveals clinically interpretable, biologically grounded multimorbidity trajectories after AMI that complement established risk scores and provide a reproducible approach to mechanistic phenotyping and precision care.
PMID:42562770 | DOI:10.1093/jamia/ocag135